AxoGen: Rev generating; addressing peripheral nerve repair w portfolio of regenerative medicine products in US, Canada et al. Products incl. Avance Nerve Graft: off-the-shelf commercially avail processed human nerve allograft bridging severed nerves w/o comorbidities assoc w addl surgical site. 3Q18 revenue ($22.7M), up 41% vs $16M (3Q17).
Healthcare/Medical Devices & Instruments
Based in...
US - South Atlantic
Clinical Stage
Marketed, Phase III
Disease Space
Central Nervous System, Pain
Biotechnology, Medical Device
Public, USA
Market Cap
500MM - 1B
13631 Progress Blvd
Suite 400
Alachua, FL 32615
United States

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Top 10 Holders of Axogen, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
ArrowMark Colorado Holdings LLC 17.05 6,726,309 88.25 13F 6/30/20
The Vanguard Group, Inc. 6.30 2,486,078 32.62 Funds 8/31/20
Essex Woodlands Management, Inc. 6.16 2,429,999 31.88 13F 6/30/20
Vanguard Group, Inc. (Subfiler) 4.57 1,802,978 23.66 13F 6/30/20
Managed Account Advisors LLC 3.91 1,544,454 20.26 13F 6/30/20
Wellington Management Co. LLP 3.73 1,473,804 19.34 Funds 6/30/20
BlackRock Fund Advisors 3.53 1,394,070 18.29 13F 6/30/20
Janus Capital Management LLC 3.28 1,295,248 16.99 13F 6/30/20
State Street Corp. 3.00 1,184,530 15.54 13F 6/30/20
Columbia Wanger Asset Management LLC 2.84 1,121,562 14.71 13F 6/30/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.